Efficacy Testing of Crassocephalum Rabens Extract Capsules
NCT ID: NCT05309161
Last Updated: 2022-08-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2022-03-14
2022-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy Testing of Chenopodium Formosanum Extracts on Skin Beauty
NCT05591352
Efficacy Testing of Hibiscus Sabdariffa Extract and Collagen Products
NCT05988554
Efficacy Evaluation of Pitaya Ovule Extract on Skin
NCT05311020
Efficacy Evaluation of Wasabi Leaf Extract on Skin
NCT05310994
Pharmacokinetics of Centella Asiatica in the Elderly
NCT03929250
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A group (placebo)
Placebo
Crassocephalum rabens extract
dosage: a capsule (180 mg)/day; duration: 1 month
B group (experimental)
Crassocephalum rabens extract
Crassocephalum rabens extract
dosage: a capsule (180 mg)/day; duration: 1 month
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Crassocephalum rabens extract
dosage: a capsule (180 mg)/day; duration: 1 month
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Healthy people
Exclusion Criteria
2. Pregnant and lactating women
3. Hypersensitivity to the assigned product
4. Diagnosed with skin diseases, liver diseases, kinedy disease, and other severe diseases
5. Cosmetic, drug, or food allergies
6. Concurrent aesthetic treatments (e.g., intense pulse light, medical peelings, or laser therapy)
7. Aceepted aesthetic treatments one month ago before the study
8. Chronic sun exposure (over 3 hours/day)
9. The members of the research team
20 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chia Nan University of Pharmacy ＆ Science
OTHER
Greenyn Biotechnology Co., Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chia-Hua Liang
Role: PRINCIPAL_INVESTIGATOR
Department of Cosmetic Science, Chia Nan University of Pharmacy ＆ Science
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chia Nan University of Pharmacy ＆ Science
Tainan City, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
21-129-A
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.